Bailard Inc. Acquires 5,494 Shares of ZimVie Inc. (NASDAQ:ZIMV)

Bailard Inc. boosted its holdings in ZimVie Inc. (NASDAQ:ZIMV) by 35.0% during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 21,194 shares of the company’s stock after acquiring an additional 5,494 shares during the quarter. Bailard Inc. owned 0.08% of ZimVie worth $296,000 at the end of the most recent quarter.

A number of other hedge funds have also added to or reduced their stakes in the stock. Segall Bryant & Hamill LLC purchased a new stake in shares of ZimVie in the third quarter valued at about $891,000. Barclays PLC boosted its holdings in ZimVie by 338.4% during the third quarter. Barclays PLC now owns 43,437 shares of the company’s stock worth $690,000 after purchasing an additional 33,529 shares during the last quarter. JPMorgan Chase & Co. increased its stake in ZimVie by 66.7% in the 3rd quarter. JPMorgan Chase & Co. now owns 183,419 shares of the company’s stock valued at $2,911,000 after buying an additional 73,395 shares during the last quarter. Geode Capital Management LLC lifted its position in shares of ZimVie by 2.4% during the 3rd quarter. Geode Capital Management LLC now owns 646,564 shares of the company’s stock worth $10,263,000 after buying an additional 15,053 shares in the last quarter. Finally, Principal Financial Group Inc. purchased a new position in shares of ZimVie in the 3rd quarter worth approximately $275,000. Institutional investors and hedge funds own 95.63% of the company’s stock.

Wall Street Analyst Weigh In

Separately, Needham & Company LLC reaffirmed a “buy” rating and set a $23.00 price target on shares of ZimVie in a research report on Thursday, February 27th.

ZimVie Trading Down 0.7 %

NASDAQ ZIMV opened at $13.35 on Thursday. The business’s fifty day moving average is $13.73 and its 200-day moving average is $14.66. The company has a debt-to-equity ratio of 0.57, a current ratio of 1.94 and a quick ratio of 1.38. The stock has a market capitalization of $369.49 million, a price-to-earnings ratio of -1.02 and a beta of 2.10. ZimVie Inc. has a one year low of $12.25 and a one year high of $22.40.

ZimVie (NASDAQ:ZIMV) last announced its quarterly earnings data on Wednesday, February 26th. The company reported $0.27 EPS for the quarter, topping the consensus estimate of $0.25 by $0.02. The business had revenue of $111.52 million for the quarter, compared to analyst estimates of $113.67 million. ZimVie had a negative net margin of 77.31% and a positive return on equity of 2.90%. Equities research analysts predict that ZimVie Inc. will post 0.6 EPS for the current year.

ZimVie Company Profile

ZimVie Inc, together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment.